Stomach Cancer Trial, Recruiting NCT06300879 Sponsor: Huashan Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06300879
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People whose cancer has been confirmed by a laboratory test to be a type called adenocarcinoma
  • People whose cancer is located in the upper part of the stomach or at the junction where the stomach meets the food pipe (a specific type called Siewert II or III)
  • People with upper stomach adenocarcinoma whose cancer is at an early stage meeting specific staging criteria called cT1N0M0 (confirm with trial site)
  • People with junction adenocarcinoma whose cancer meets specific early staging criteria called cT1-2N0M0, with no sign of cancer spread to distant lymph nodes (confirm with trial site)
  • People whose surgery would leave clear margins of more than 2 cm on both sides, and where more than half of the stomach can be kept
  • People who have not had previous upper abdominal surgery (having had a keyhole gallbladder removal is acceptable)
  • People who have not had chemotherapy, radiation, targeted therapy, or immunotherapy before surgery
  • People with a good general activity level before surgery, rated 0 or 1 on a standard medical scale (confirm with trial site)
  • People considered fit enough for anaesthesia, rated within a specific range on a standard anaesthesia assessment scale (confirm with trial site)
  • People whose major organs such as the heart, liver, and kidneys are functioning well
  • People who have given signed agreement to take part in the trial

Who may not be able to join:

  • People whose pre-surgery assessment shows the cancer has grown into nearby structures, or shows significantly enlarged or distantly spread lymph nodes
  • People who are pregnant or breastfeeding
  • People with a severe mental illness
  • People with a temperature of 38°C or higher before surgery, or who have an infection requiring treatment throughout the body
  • People with serious lung disease where breathing tests show lung function below 50% of the expected level
  • People who have had another type of cancer in the past 5 years
  • People with severe liver or kidney problems
  • People who have had unstable chest pain or a heart attack in the past 6 months
  • People who have had a stroke or brain bleed in the past 6 months (not including old, previously treated infarcts)
  • People who have used steroid medications throughout their body in the past month
  • People who need emergency surgery because of a stomach cancer complication such as bleeding, a hole in the stomach wall, or blockage
  • People who have taken part in, or are currently taking part in, another clinical trial within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Huashan Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Assess intraoperative Perioperative Safety by Duration of surgery.; Assess intraoperative Perioperative Safety by Duration of anastomosis.; Assess intraoperative Perioperative Safety by blood loss .; Postoperative recovery course; Postoperative TNM staging by Pathological findings .

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov